WO2002063004A3 - Recepteurs couples a la proteine g - Google Patents

Recepteurs couples a la proteine g Download PDF

Info

Publication number
WO2002063004A3
WO2002063004A3 PCT/US2002/003635 US0203635W WO02063004A3 WO 2002063004 A3 WO2002063004 A3 WO 2002063004A3 US 0203635 W US0203635 W US 0203635W WO 02063004 A3 WO02063004 A3 WO 02063004A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein coupled
coupled receptors
gcrec
provides
polynucleotides
Prior art date
Application number
PCT/US2002/003635
Other languages
English (en)
Other versions
WO2002063004A2 (fr
Inventor
Mariah R Baughn
Catherine M Tribouley
Danniel B Nguyen
Michael Thornton
Original Assignee
Incyte Genomics Inc
Mariah R Baughn
Catherine M Tribouley
Danniel B Nguyen
Michael Thornton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Mariah R Baughn, Catherine M Tribouley, Danniel B Nguyen, Michael Thornton filed Critical Incyte Genomics Inc
Priority to EP02718924A priority Critical patent/EP1366165A2/fr
Priority to CA002437717A priority patent/CA2437717A1/fr
Priority to JP2002562741A priority patent/JP2005503111A/ja
Priority to US10/467,252 priority patent/US20040115676A1/en
Publication of WO2002063004A2 publication Critical patent/WO2002063004A2/fr
Publication of WO2002063004A3 publication Critical patent/WO2002063004A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des récepteurs humains couplés à la protéine G (GCREC), ainsi que des polynucléotides qui identifient et codent GCREC. L'invention concerne également des vecteurs d'expression, cellules hôtes, anticorps, agonistes et antagonistes. L'invention concerne également des procédés permettant le diagnostic, le traitement ou la prévention de troubles associés à une expression aberrante de GCREC.
PCT/US2002/003635 2001-02-07 2002-02-06 Recepteurs couples a la proteine g WO2002063004A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02718924A EP1366165A2 (fr) 2001-02-07 2002-02-06 Recepteurs couples a la proteine g
CA002437717A CA2437717A1 (fr) 2001-02-07 2002-02-06 Recepteurs couples a la proteine g
JP2002562741A JP2005503111A (ja) 2001-02-07 2002-02-06 Ｇタンパク質共役受容体
US10/467,252 US20040115676A1 (en) 2002-02-06 2002-02-06 G-protein coupled receptors

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US26732201P 2001-02-07 2001-02-07
US60/267,322 2001-02-07
US27121501P 2001-02-23 2001-02-23
US60/271,215 2001-02-23
US27455101P 2001-03-08 2001-03-08
US60/274,551 2001-03-08
US27850701P 2001-03-23 2001-03-23
US60/278,507 2001-03-23
US28059701P 2001-03-30 2001-03-30
US60/280,597 2001-03-30
US28110701P 2001-04-02 2001-04-02
US60/281,107 2001-04-02
US28212101P 2001-04-06 2001-04-06
US60/282,121 2001-04-06

Publications (2)

Publication Number Publication Date
WO2002063004A2 WO2002063004A2 (fr) 2002-08-15
WO2002063004A3 true WO2002063004A3 (fr) 2003-09-25

Family

ID=27569524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/003635 WO2002063004A2 (fr) 2001-02-07 2002-02-06 Recepteurs couples a la proteine g

Country Status (4)

Country Link
EP (1) EP1366165A2 (fr)
JP (1) JP2005503111A (fr)
CA (1) CA2437717A1 (fr)
WO (1) WO2002063004A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507638A (ja) * 2001-03-01 2005-03-24 ミレニウム ファーマシューティカルズ，インコーポレーテッド ヒトｇタンパク質共役型受容体９３８７０およびその使用
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
AU2003236351A1 (en) * 2002-04-03 2003-10-27 Banyu Pharmaceutical Co., Ltd. Novel g protein-coupled receptor gene and protein bg8
JP2004242644A (ja) * 2002-12-18 2004-09-02 National Institute Of Advanced Industrial & Technology グアノシン三リン酸結合タンパク質共役型の受容体
AU2003292273A1 (en) * 2002-12-20 2004-07-14 Karolinska Institutet Innovations Ab Asthma susceptibility locus
WO2004104596A2 (fr) * 2003-05-22 2004-12-02 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees a igs70 (igs70)
US7189539B2 (en) 2003-11-25 2007-03-13 Bristol-Myers Squibb Company Polynucleotide encoding a human relaxin receptor, HGPRBMY5v1

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048921A1 (fr) * 1998-03-26 1999-09-30 The Board Of Trustees Of The Leland Stanford Junior University Nouveaux recepteurs de mammiferes couples a la proteine g et presentant des zones de repetition riches en leucine
WO2000015793A2 (fr) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Proteines gpcr humaines
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2002004640A1 (fr) * 2000-07-07 2002-01-17 Takeda Chemical Industries, Ltd. Nouvelle proteine du type recepteur couple aux proteines g et adn correspondant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048921A1 (fr) * 1998-03-26 1999-09-30 The Board Of Trustees Of The Leland Stanford Junior University Nouveaux recepteurs de mammiferes couples a la proteine g et presentant des zones de repetition riches en leucine
WO2000015793A2 (fr) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Proteines gpcr humaines
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2002004640A1 (fr) * 2000-07-07 2002-01-17 Takeda Chemical Industries, Ltd. Nouvelle proteine du type recepteur couple aux proteines g et adn correspondant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENESEQ [online] 23 May 2002 (2002-05-23), "Human G protein-coupled receptor TGR17-6 protein SEQ ID NO:15", XP002233600, retrieved from GENESEQ Database accession no. ABB06255 *

Also Published As

Publication number Publication date
CA2437717A1 (fr) 2002-08-15
WO2002063004A2 (fr) 2002-08-15
JP2005503111A (ja) 2005-02-03
EP1366165A2 (fr) 2003-12-03

Similar Documents

Publication Publication Date Title
WO2001098351A3 (fr) Recepteurs couples a la proteine g
WO2001042288A3 (fr) Recepteurs couples a la proteine g
WO2001057085A3 (fr) Récepteurs couplés aux protéines g
WO2001087937A3 (fr) Recepteurs couples aux proteines g
WO2003027228A3 (fr) Recepteurs et proteines associees a une membrane
WO2002010387A3 (fr) Récepteurs couplés à la protéine g
WO2001098323A3 (fr) Recepteurs couples a la proteine g
WO2003048305A3 (fr) Recepteurs et proteines associees aux membranes
WO2001098354A3 (fr) Recepteurs
WO2002072794A3 (fr) Proteines de la superfamille des immunoglobulines
WO2001072836A3 (fr) Recepteurs couples a une proteine g
WO2003070902A3 (fr) Recepteurs et proteines associees aux membranes
WO2002094990A3 (fr) Recepteurs et proteines associees aux membranes
WO2001090359A3 (fr) Recepteurs couples par proteine g
WO2002026825A3 (fr) Récepteurs couplés à la protéine g
WO2001066742A3 (fr) Recepteurs couples a la proteine g
WO2002063004A3 (fr) Recepteurs couples a la proteine g
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2003025130A3 (fr) Recepteurs et proteines associees a la membrane
WO2004100774A3 (fr) Recepteurs et proteines associees a une membrane
WO2002057454A3 (fr) Proteines associees a une membrane et a des recepteurs
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2002079448A3 (fr) Récepteurs couplés à la protéine g
WO2003023009A3 (fr) Recepteurs couples a la proteine g
WO2002063006A3 (fr) Recepteurs et proteines associees aux membranes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10467252

Country of ref document: US

Ref document number: 2437717

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002562741

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002718924

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002718924

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002718924

Country of ref document: EP